Six variations of KIF1C that lead to decreased expression levels are identified in patients with left atrial myxoma (LAM). Inhibition of KIF1C promote LAM pathogenesis through a positive feedback formed by the crosstalk between KIF1C and PRKAR1A.
- Mengchen Zhou
- Yan Yao
- Xin Tu